Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Medical Genetics · Carbonic Anhydrase VA Deficiency

Inside the Mitochondria: The Biology of CA-VA Deficiency

At a Glance

CA-VA deficiency is an inherited condition in which both copies of the CA5A gene are altered, reducing a mitochondrial enzyme that helps make bicarbonate. Ammonia can then build up and energy pathways can be disrupted, causing metabolic crises, and genetic testing is used to confirm the diagnosis.

To understand Carbonic Anhydrase VA (CA-VA) deficiency, it helps to think of the mitochondria (the energy-producing parts of your child’s cells) as a complex factory. For this factory to run, it needs raw materials. One of the most important materials is bicarbonate [1].

The CA5A gene provides the instructions for making the CA-VA enzyme, which lives inside the mitochondria [2]. Its job is to rapidly create bicarbonate from carbon dioxide and water [1]. When this enzyme is missing, several major “assembly lines” in the factory slow down or stop, leading to the metabolic crises seen in this condition.

The Missing Ingredient

The lack of bicarbonate affects several critical enzymes that depend on it to function. These include:

  • CPS1 (Carbamoyl-phosphate synthetase I): This is the first step in the urea cycle, the system that clears toxic ammonia from the body [2]. With reduced bicarbonate, CPS1 reduces activity, and ammonia levels rise (hyperammonemia) [3].
  • Pyruvate Carboxylase: This enzyme helps the body make glucose (blood sugar) and manage energy. When its activity is impaired, the body may experience low blood sugar (hypoglycemia) and a buildup of lactate (lactic acid) [4][2].
  • Other Carboxylases: Enzymes like propionyl-CoA carboxylase are also affected, which can further disrupt how the body processes fats and proteins [2].

The Suggestive Metabolic Pattern

Because CA-VA deficiency affects multiple pathways at once, it creates a suggestive metabolic pattern during a crisis. While other metabolic disorders might only show one or two of these signs, children with CA-VA deficiency may show some or all of them simultaneously [3]:

  1. Hyperammonemia: High levels of ammonia in the blood.
  2. Lactic Acidosis: High levels of lactate, making the blood too acidic [5].
  3. Ketonuria: The presence of ketones (byproducts of fat breakdown) in the urine [6].
  4. Metabolic Acidosis: An overall “acidic” state in the body’s chemistry.
  5. Hypoglycemia: Occasionally, low blood sugar levels are also present [3].

It is important to note that these findings overlap with urea-cycle disorders, organic acidemias, and fatty-acid disorders; absence of one finding does not exclude CA-VA deficiency.

Why Diagnosis is a Challenge

Diagnosing CA-VA deficiency is tricky because its initial pattern looks very much like other, more common metabolic disorders. For example, the high ammonia and certain amino acid patterns can closely mimic OTC deficiency (Ornithine Transcarbamylase deficiency), a more well-known urea cycle disorder [5].

Routine tests like plasma amino acids (which may show high glutamine) or urine organic acids (which may show high orotic acid) are essential first steps, but they often cannot provide a “smoking gun” that points only to CA-VA [5][3]. This is why children with this condition were often misdiagnosed in the past before genetic testing became widely available.

The Role of Genetic Testing

A definitive diagnosis requires genetic testing to find “biallelic” variants in the CA5A gene—meaning the child inherited one mutated copy from each parent [7][8].

Common ways this is diagnosed include:

  • Whole Exome Sequencing (WES): A broad test that looks at all the genes in the body. This is often how rare conditions like CA-VA are discovered when other tests are inconclusive [9].
  • Targeted Panels: A test specifically looking at genes related to hyperammonemia or metabolic disorders.
  • Deletion/Duplication Analysis: Because some CA5A mutations involve large “missing” chunks of DNA, specialized testing is sometimes needed to find them [7].

Confirming the diagnosis through genetics is vital because it changes how the child is treated. A variant of uncertain significance does not establish the diagnosis, and a negative test may require specialist review for structural or hard-to-detect variants (like CA5A “pseudogenes”).

Common questions in this guide

Why does CA-VA deficiency cause ammonia to build up?
The CA-VA enzyme makes bicarbonate inside mitochondria. Bicarbonate is needed for CPS1, the first step of the urea cycle, which removes ammonia; when CA-VA is deficient, ammonia clearance can slow and blood ammonia can rise.
What blood and urine findings can occur during a CA-VA crisis?
A crisis may involve high blood ammonia, high lactate, ketones in the urine, and metabolic acidosis; low blood sugar can also occur. This combination can overlap with urea-cycle, organic-acid, and fatty-acid disorders, so one missing finding does not rule out CA-VA deficiency.
How is carbonic anhydrase VA deficiency confirmed?
Confirmation usually requires genetic testing that identifies disease-causing variants in both copies of the CA5A gene. Testing may include whole-exome sequencing, a metabolic or hyperammonemia panel, and deletion/duplication analysis when larger missing DNA segments are suspected.
Why can CA-VA deficiency be mistaken for OTC deficiency?
Both conditions can cause high ammonia and similar amino-acid or urine findings, including increased glutamine or orotic acid. Routine blood and urine tests may therefore suggest a urea-cycle disorder without distinguishing CA-VA deficiency, making genetic testing important.
What does it mean to have two CA5A variants?
It means the child inherited an altered CA5A copy from each parent, a pattern called biallelic inheritance. The laboratory must determine that the variants are pathogenic or likely pathogenic; a variant of uncertain significance alone does not confirm CA-VA deficiency.
Can genetic testing miss CA-VA deficiency?
Some tests may miss large deletions, duplications, or difficult-to-detect changes involving CA5A, so deletion/duplication analysis or specialist review may be needed. A negative result does not always end the evaluation when the clinical and laboratory pattern remains concerning.

Get notified when new evidence is published on Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Mitochondrial carbonic anhydrases VA and VB: Metabolic roles and clinical significance.

    Kalinin S, Parkkila S, Aspatwar A

    The Enzymes 2026; (59()):105-130 doi:10.1016/bs.enz.2026.05.002.

    PMID: 42486544
  2. 2

    Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease.

    Aspatwar A, Supuran CT, Waheed A, et al.

    The Journal of physiology 2023; (601(2)):257-274 doi:10.1113/JP283579.

    PMID: 36464834
  3. 3

    Defective hepatic bicarbonate production due to carbonic anhydrase VA deficiency leads to early-onset life-threatening metabolic crisis.

    Diez-Fernandez C, Rüfenacht V, Santra S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2016; (18(10)):991-1000 doi:10.1038/gim.2015.201.

    PMID: 26913920
  4. 4

    The Role of Carbonic Anhydrase in Hepatic Glucose Production.

    Ismail IS

    Current diabetes reviews 2018; (14(2)):108-112 doi:10.2174/1573399812666161214122351.

    PMID: 27981898
  5. 5

    Two cases of carbonic anhydrase VA deficiency-An ultrarare metabolic decompensation syndrome presenting with hyperammonemia, lactic acidosis, ketonuria, and good clinical outcome.

    Marwaha A, Ibrahim J, Rice T, et al.

    JIMD reports 2021; (57(1)):9-14 doi:10.1002/jmd2.12171.

    PMID: 33473334
  6. 6

    Carbonic anhydrase VA deficiency due to a novel CA5A variant.

    Keehan L, Null E, Chilakamarri L, et al.

    Molecular genetics and metabolism reports 2025; (45()):101259 doi:10.1016/j.ymgmr.2025.101259.

    PMID: 41113665
  7. 7

    A novel homozygous CA5A gene deletion in carbonic anhydrase VA deficiency presenting as developmental delay without metabolic crisis.

    Bin Hadyan MF, Saleh MA, Aldalaqan S, et al.

    Molecular genetics and metabolism reports 2026; (46()):101294 doi:10.1016/j.ymgmr.2026.101294.

    PMID: 41736722
  8. 8

    Mitochondrial carbonic anhydrase VA deficiency in three Indian infants manifesting early metabolic crisis.

    Konanki R, Akella RRD, Panigrahy N, et al.

    Brain & development 2020; (42(7)):534-538 doi:10.1016/j.braindev.2020.04.007.

    PMID: 32381389
  9. 9

    Carbonic anhydrase VA deficiency: a very rare case of hyperammonemic encephalopathy.

    Olgac A, Kasapkara CS, Kilic M, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(10)):1349-1352.

    PMID: 32809955

This page is for informational purposes only and does not constitute medical advice. A metabolic specialist or geneticist should interpret your child’s results and guide care for CA-VA deficiency.